#23 Jennifer Brudno: CAR-T and NIH The Graft

Dr. Brudno researches the use of chimeric antigen receptor (CAR) T-cell  therapy to treat cancers of the blood, including Non-Hodgkin lymphoma,  Hodgkin lymphoma, acute lymphoblastic leukemia (ALL), and multiple  myeloma. Her focus is in the development of phase I clinical trials. She  is also interested in patient safety, particularly in optimizing  patient safety for cellular immunotherapies.

Nico Gagelmann and Jennifer Brudno

ALL EPISODES AS AUDIO 

APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846  

SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab 

GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw==

CONNECT WITH US

https://twitter.com/TheEBMT_Trainee 

https://www.ebmt.org/trainee-committee 

https://twitter.com/NicoGagelmann 

https://twitter.com/Claire_P_Horgan